OmniAb to Host Investor & Analyst Day on October 6, 2026
OmniAb Inc OABI
$4.61
▼ -3.76%
($-0.18)
⬇️ Below Yest. Low
Open
$4.82
Prev Close
$4.79
Day Range
$4.59 – $4.84
52W Range
$1.30 – $5.43
Market Cap
$670.25M
Beta
0.61
EPS (TTM)
$-0.36
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-10-09 |
| Shares Out. | 144,970,000 |
| Website | omniab.com/ ↗ |
| Phone | 13026365400 |
| Employees | 89 |
| Revenue | $13.4M |
| Gross Profit | $12.8M |
| Net Income | -$5.9M |
| Free Cash Flow | -$18.1M |
| Total Assets | $290.3M |
| Total Liabilities | $30.0M |
| Equity | $260.3M |
About OmniAb Inc
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
OmniAb Inc is a publicly traded company under the ticker symbol OABI on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-09-01)